Philips to Acquire Capsule Technologies Inc.

Royal Philips has signed an agreement to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations.

Camber Spine Expands Patent Portfolio with SPIRA Lateral 3.0

Camber Spine has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its SPIRA Lateral 3.0 interbody fusion implant.

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

COVID-19 Update: FDA’s New Policy for Infusion Pump Manufacturers

Today, the U.S. Food and Drug Administration (FDA) issued an immediately in effect guidance, Enforcement Policy for Infusion Pumps and Accessories During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, that provides regulatory flexibility for manufacturers of certain FDA-cleared infusion pumps and accessories to help expand the availability of these products.

This guidance is intended to help ensure health care providers can maintain an adequate supply of devices for patients who require continuous infusion of medications, nutrition, and/or other fluids and help foster technologies that maintain a safer physical distance between the health care provider and the patient, such as adding remote capabilities. The devices include large volume parenteral (LVP) infusion pumps, syringe infusion pumps, patient-controlled analgesic (PCA) infusion pumps, and ambulatory infusion pump devices, and their accessories.

The guidance outlines an approach for certain modifications to the indications, functionality, hardware, software, design or materials of these devices without submission of a new 510(k).

This policy reflects the FDA’s commitment to ease burdens on health care providers and facilities as they face the COVID-19 public health emergency.




Submit a Comment

Your email address will not be published. Required fields are marked *